해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)

구분	보고서 (영문)
제약/ 바이오/ 임상시험 (3건)	FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
	New Drug Approvals and Their Contract Manufacture: 2024 Edition
	Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
질환별 (8건)	Cell & Gene Therapies in Rheumatology
	Acne Vulgaris: Competitive Landscape
	Study Explores the Effects of State Medicaid Policies on Hepatitis C Treatment
	Methicillin-Resistant Staphylococcus aureus (MRSA): Epidemiology Forecast to 2033
	Changing Epidemiology of Atopic Dermatitis in South Korea
	New WHO Hepatitis B Guidelines Address Testing and Treatment Barriers
	Syphilis, the Once Near-Eliminated STI, Is Resurging in the US
	PPD Affects Races Similarly, Inequities Lie in Mental Healthcare
컨퍼런스/ 심포지엄/ 학회/기타 (13건)	ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
	The Wolbachia Method in the Battle Against Dengue
	ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
	Extended Time Spent Indoors in School Increases the Risk of Shortsightedness
	India Sees Insignificant Revision to Price Ceiling in 2024
	AAN 2024: Myostatin Inhibitors on the Horizon for the Treatment of SMA
	AAN 2024: Amneal Showcases IPX203’s Safety Profile in Anticipation of FDA Approval
	AAN 2024: AbbVie Highlights Long-Term Safety of Atogepant in Migraine Prevention
	AAN 2024: Biomarker Data Shows Promise for Alzheon’s Oral Anti-Amyloid Drug
	AAN 2024: Importance of Early Diagnosis and Prompt Treatment in SMA
	AAN 2024: Four-Year Follow-Up of Roche’s PRX-002 Encouraging for Parkinson’s Disease
	AAN 2024: New Pooled Data Highlights Efficacy of Axsome Therapeutics’s AXS-07
	AAN 2024: Pharma Two B’s P2B001 Shows Promise in Early PD
	AAN 2024: Monitoring Adverse Events Associated with Gene Transfer Therapies